Product Highlight - Toujeo
07 Apr 2021
Confidence in Every Step1-6
The only 450-unit Insulin Glargine in the market7
- Treatment of type 2 diabetes mellitus in adults to lower blood sugar steadily
over a long period of time.7 - Highly effective in lowering HbA1c for a broad range of patient types8-11
- Proven safe with lesser risk of hypoglycemia vs. U100 and other 2nd gen
basal insulins8-11 - Flatter profile and less within-day fluctuations vs. other 2nd gen basal insulins12
REFERENCES:
(1) Rosenstock J, et al. Diabetes Care. 2018 Oct 1;41/(10):2147-54.
(2) Riddle MC et al. Diabetes Care 2014 Oct.37(10)2755-62.
(3) Yki-Jarvinen H et al Diabetes Care 2014 Dec 37(12)3235-74.
(4) Boli GB et al Diabetes Obes Metab 2015 Apr. 17(4)386-94.
(5) Terauchi Y at al Diabetes Obes Metab 2016 Apr 18(4) 366-74.
(6) Home PD et al Diabetes Care 2015 Dec 38(12)2217-25 7. Matsuhisa M et al. Diabetes Obes Metab 2016 Apr 18(4) 375-83
(7) Toujeo Prescribing Info 2016.
(8) Haluzik M. et.al Presented at 79th ADA 2019, June 7-11, SA, CA, US 146-OR.
(9) Escalada FJ, et.al Diabetes Obes Metab, 2018;20:2860-2868.
(10) Sullivan SD, et al. Presented at 79th ADA 2019, June 7-11, SA, CA, US 133-LB.
(11) Charbonnel et al. Presented at 79th ADA 2019, June 7-11, SA, CA, US 133-LB.
(12) Bailey et al. DOM Accepted.
sanofi-aventis Phils. Inc.
Unit 2103 & 2105 One World Place Corporate Offices,
32nd St. Bonifacio Global City,
Taguig City 1634, Metro Manila.
Website: www.sanofi.ph
